We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.50 | -2.70% | 90.00 | 85.00 | 95.00 | 92.50 | 90.00 | 92.50 | 3,610 | 08:21:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Electronic Computers | 1.03M | -2.92M | -0.2188 | -4.11 | 12M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/9/2022 16:07 | September it is then. Was hoping they were going to release it in October as a birthday present to me. | lr2 | |
12/9/2022 16:05 | Thanks for the name change, LR2. EDIT Damn, I need to change the link in the header From the update 17th June:- 'The Company will provide further information at the time of its full year results announcement, expected in September 2022.' | ged5 | |
12/9/2022 16:02 | Ged, the results usually come out mid-October onwards so still a bit of a wait. Future Processing's medical IT division are calling themselves Graylight nowadays - you can find their Bleepa page below. | lr2 | |
11/9/2022 07:36 | “The hospital staff are learning to use this new technology and once fully proficient will enable us to identify more TB cases in less time, start treatment early and save more lives” This trial has been ongoing for some time. I would imagine the staff should be “fully proficient” by now. News soon hopefully. | ducatiman | |
10/9/2022 10:09 | It is indeed nice coverage. Thanks for sharing, Paleje. Great to see you're still following FDBK. Another couple of good commendations from the doctors using Bleepa. Maybe still early days to expect contracts in India but who knows? Either India or the CDCs could be game changers. Still not had any updates from the veterinary sector. CVS contract renewal? | ged5 | |
10/9/2022 09:53 | Nice coverage in the Indian press yesterday. | paleje | |
07/9/2022 11:11 | India update - perhaps. Final results - mid October. | lr2 | |
07/9/2022 10:07 | Next news? | ducatiman | |
07/9/2022 09:06 | To be fair, it is good news, even though a non-renewal would erm, well… Lets hope lots of small steps lead to some significant big ones. When you listen to what the system does, you wonder why it has not been addressed before. I hope to goodness it gets adopted across the CDC’s because the failings and inefficiencies of the single GP to consultant referral system are very obvious to anyone who does not have clear cut single issue symptoms. Perhaps revising the entrenched existing systems was always a non-starter and something separate sitting on top of them is THE solution. I’ll be retiring in a few years so looking for the ideal of a multiple of the share price and the benefits of using a cdc for any complaints that I might need treatment for. Yes I know they can’t treat pessimism. | yump | |
07/9/2022 09:04 | LR2 ;-) Unfortunately can’t use handbags any more it might offend someone. | yump | |
06/9/2022 23:57 | Decent interview and it does seem we are getting there but not at Ferrari speed. | digger2779 | |
06/9/2022 19:59 | Very difficult to be in any way negative about today’s news LR2! | ducatiman | |
06/9/2022 18:49 | Yump - Member since: 11 Dec 2000 ydderF - Member since: 11 Aug 2000 Think I might need to see both of you in the same room at the same time. :) | lr2 | |
06/9/2022 18:44 | Your name's not Trevor is it, Yump? | lr2 | |
06/9/2022 18:13 | The RNS also states that the value of this contract was discounted so the full procurement should be substantially more assuming it will be for additional pathways. | ragnarr | |
06/9/2022 18:00 | Well I am disappointed in today’s gains. I thought it was a hugely positive RNS. I may be becoming a believer. Holding tight. | ducatiman | |
06/9/2022 14:00 | LR2 I guess that will be fine if the other CDC’s just go with the blueprint or something close to it. However, unless there is some unifying authority to get CDC’s to use it, my experience is that organisations run by different folk will have the not-invented-here issue. I’ve had to sell the same product into a multi-site organisation, at site level in the past, despite fairly straightforward proof of product success at one site - and that was in manufacturing, where proof was easily measurable and only a few stakeholders. So I’ll believe it when I see it. | yump | |
06/9/2022 13:57 | Formal process is requirement of NHS procurement policy. But I think it’s fair to say Bleepa are the clear front runners. | petekand | |
06/9/2022 13:44 | £450k is a lot for a Bleepa pilot extension. I reckon they are going to seal the deal eventually and I am turning more positive after having pondered over the reading in between the lines. | petekand |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions